Use of Telomere Length in Peripheral Leukocytes to Predict Risk of Recurrence in Patients with Early-Stage Non-Small Cell Lung Cancer after Curative Resection.

E. S. Kim,A. A. Vaporciyan,J. Xing,M. Huang,M. R. Spitz,S. M. Lippman,J. Gu,J. A. Roth,X. Wu

DOI: https://doi.org/10.1200/jco.2010.28.15_suppl.7031

IF: 45.3

2010-01-01

Journal of Clinical Oncology

Abstract:7031 Background: Telomeres play a key role in maintaining chromosome stability. Shorter telomere length has been demonstrated to be a risk factor for lung cancer. A significant number of patients with non-small cell lung cancer (NSCLC) will develop recurrence after curative resection. To potentially identify this subgroup of patients, we hypothesized that telomere length in peripheral blood would have significant predictive value for risk of recurrence. Methods: Relative telomere length (RTL) of peripheral leukocytes was measured by real-time PCR in 403 patients with early stage NSCLC who underwent curative resection at M. D. Anderson Cancer Center between 1991 and 2007. The risk of recurrence was estimated as hazard ratios (HRs) and 95% confidence intervals (CIs) using a multivariable Cox proportional hazard regression model. Results: Median duration of follow- up was 29.9 months (0.1-158.8 months) and 87 patients (21.6%) had developed recurrence at time of analysis. 60 patients (14.9%) received chemotherapy (mostly adjuvant) with surgery. Our results show that the recurrence group demonstrated significantly longer mean RTL compared to the nonrecurrence group (1.19 vs. 1.07, p=0.003). Furthermore, the risk of recurrence increased as telomere length increased (p-trend=0.004). When 75th percentile value of RTL was used to dichotomize telomere length, patients with long telomeres were at higher risk of recurrence (HR=1.72; 95% CI, 1.08-2.72, p =0.021). This increased risk was most pronounced in adenocarcinoma subgroup (HR=2.28; 95% CI, 1.31-3.98, p = 0.004). When categorized into surgery only or surgery and chemotherapy group, longer telomeres increased risk of recurrence in the surgery only group (HR=1.81; 95% CI, 1.06-3.11, p=0.031). However, this association was not evident in the chemotherapy group (HR=1.13; 95% CI, 0.34-3.70, p=0.85). Conclusions: This is the first study to suggest that long telomere length is associated with increased risk of recurrence in early stage NSCLC after curative resection. Chemotherapy may be considered to overcome this increased risk. This study is supported by NCI CA 111646, CA 55769, and CA 70907. No significant financial relationships to disclose.